The government is preparing to buy enough experimental anthrax vaccine for 25 million people, a stockpile that would permit mass inoculations in numerous U.S. cities if terrorists launched a broad assault with the deadly germ.
The government is preparing to buy enough experimental anthrax vaccine for 25 million people, a stockpile that would permit mass inoculations in numerous U.S. cities if terrorists launched a broad assault with the deadly germ.